AU4000500A - Co-administration of a thrombolytic and an anti-cd18 antibody - Google Patents

Co-administration of a thrombolytic and an anti-cd18 antibody

Info

Publication number
AU4000500A
AU4000500A AU40005/00A AU4000500A AU4000500A AU 4000500 A AU4000500 A AU 4000500A AU 40005/00 A AU40005/00 A AU 40005/00A AU 4000500 A AU4000500 A AU 4000500A AU 4000500 A AU4000500 A AU 4000500A
Authority
AU
Australia
Prior art keywords
thrombolytic
antibody
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40005/00A
Inventor
Hal V. Barron
Paula M. Jardieu
G. Roger Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU4000500A publication Critical patent/AU4000500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU40005/00A 1999-02-17 2000-02-14 Co-administration of a thrombolytic and an anti-cd18 antibody Abandoned AU4000500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25165299A 1999-02-17 1999-02-17
US09251652 1999-02-17
PCT/US2000/003800 WO2000048681A2 (en) 1999-02-17 2000-02-14 Co-administration of a thrombolytic and an anti-cd18 antibody

Publications (1)

Publication Number Publication Date
AU4000500A true AU4000500A (en) 2000-09-04

Family

ID=22952858

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40005/00A Abandoned AU4000500A (en) 1999-02-17 2000-02-14 Co-administration of a thrombolytic and an anti-cd18 antibody

Country Status (2)

Country Link
AU (1) AU4000500A (en)
WO (1) WO2000048681A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935234A (en) * 1987-06-11 1990-06-19 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US4797277A (en) * 1987-09-22 1989-01-10 Pharmacia Ab Method for reperfusion therapy
WO1991019511A1 (en) * 1990-06-18 1991-12-26 The General Hospital Corporation CONTROLLING CELLULAR IMMUNE/INFLAMMATORY RESPONSES WITH β2 INTEGRINS
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
ES2183131T3 (en) * 1996-01-23 2003-03-16 Genentech Inc ANTI-CD18 ANTIBODIES USED AGAINST CEREBRAL ICTUS.

Also Published As

Publication number Publication date
WO2000048681A3 (en) 2000-12-14
WO2000048681A2 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
AU6688898A (en) Methods and materials for degrading xanthan
AUPQ198899A0 (en) A method of magnet design and magnet configuration
AU3380800A (en) Magnetic coupler and various embodiments thereof
AU2062301A (en) A method and system for discovery of trades between parties
AU4799200A (en) Vortex static mixer and method employing same
AU3622600A (en) Metalloproteinases and methods of use therefor
AU2002223626A1 (en) Combinations of a thyromimetic compound and a statin
AU4843500A (en) Destructible surfactants and uses thereof
AU6303898A (en) Component of bromelain
AU3726801A (en) Liner and carton
AU7849200A (en) Mannosidases and methods for using same
AU4014700A (en) Tuberculosis antigens and methods of use therefor
AU6992500A (en) Alphavbeta3 integrin inhibitors
AU2662799A (en) Modified pharmacologically active agents and improved therapeutic methods employing same
AU4000500A (en) Co-administration of a thrombolytic and an anti-cd18 antibody
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AU5115800A (en) An underreamer and a method of using the underreamer
AU6523498A (en) 4-benzoylpyrazole derivatives and herbicides
AU2694200A (en) Itchiness-relieving agents and itchiness-relieving effect potentiators
AU6084598A (en) Antibiotic-ligand conjugates and methods of use thereof
AU3078400A (en) Describing and storing method of alignment information
AU5014700A (en) Novel integrin alphasubunit and uses thereof
GB2346869B (en) Improved carton and method of construction therefor
AU2567599A (en) Anti-ccr1 antibodies and methods of use therefor
AU6396399A (en) Package and method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase